InvestSMART

Global Health Limited (ASX:GLH)

ALERT: Price-sensitive ASX Announcement for GLH
Current share price for GLH : $0.065 -0.005 (-7.14%)+
Announcement
Release
25 Feb 2026 2:40PM
Price at Release
$0.070
Full Release
download
Summary
Global Health Limited has reported a consolidated loss of $629,201 for the half year ended 31 December 2025, which is a reduction in loss compared to the previous period. The company's revenue from ordinary activities decreased slightly by 1.19% to $3,593,758. The company continues to focus on developing and supporting healthcare software solutions, with a strategic shift towards a more stable and recurring SaaS revenue model. This transition is evidenced by an increase in Monthly Recurring Revenue (MRR) by 2.3% and a reduction in professional services revenue due to a move towards standardized SaaS onboarding. Despite these changes, the company noted improvements in EBITDA by 18% year-on-year. Efforts to integrate AI into product development and collaboration with partners like Best Practice are ongoing. No dividends were paid or declared during the period, and the company maintains a net asset deficiency. The directors are confident in the company's ability to continue as a going concern.
Key Points
  • Consolidated loss for the half year was $629,201.
  • Revenue from ordinary activities decreased by 1.19% to $3,593,758.
  • Shift towards SaaS revenue model with a 2.3% increase in MRR.
  • EBITDA improved by 18% year-on-year.
  • Focus on AI integration and partnerships, including Best Practice.
  • No dividends were paid or declared.
  • Company maintains a net asset deficiency.
  • Directors express confidence in going concern status.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.